Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis.
about
Cytokines as Mediators of Pain-Related Process in Breast CancerIntracellular innate immunity in gouty arthritis: role of NALP3 inflammasomeUrate crystal induced inflammation and joint pain are reduced in transient receptor potential ankyrin 1 deficient mice--potential role for transient receptor potential ankyrin 1 in goutMonosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis?[The etiology and management of gout].Interactions between the immune and nervous systems in pain.Animal model of acute gout reproduces the inflammatory and ultrasonographic joint changes of human gout.An update on the pathology and clinical management of gouty arthritis.The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases.Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgeryLack of association of -607 C/A and -137 G/C polymorphisms in interleukin 18 gene with susceptibility to gout disease in Chinese Han male populationConcordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targetsCutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse modelsLatest evidence on gout management: what the clinician needs to knowIL-1 receptor regulates microRNA-135b expression in a negative feedback mechanism during cigarette smoke-induced inflammation.Uric acid as a danger signal in gout and its comorbiditiesRilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.Zisheng Shenqi decoction ameliorates monosodium urate crystal-induced gouty arthritis in rats through anti-inflammatory and anti-oxidative effects.Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer.Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression.Role of melanocortin receptors in the regulation of gouty inflammation.The role of the NLRP3 inflammasome in gout.Recent advances in management of gout.Neutrophils, IL-1β, and gout: is there a link?Uric acid and xanthine oxidoreductase in wound healing.Nociception and role of immune system in pain.Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.The inflammasome as a target for pain therapy.Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages.Cytokine Profile in Gout: Inflammation Driven by IL-6 and IL-18?Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout.Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.A variant allele of the Mediterranean-fever gene increases the severity of gout.Macrophage-derived IL-1β enhances monosodium urate crystal-triggered NET formation.Ozonated autohemotherapy modulates the serum levels of inflammatory cytokines in gouty patients.Gout: will the "King of Diseases" be the first rheumatic disease to be cured?Polymorphisms in Cytokine Genes Are Associated With Higher Levels of Fatigue and Lower Levels of Energy in Women After Breast Cancer Surgery.5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.Trikatu, a herbal compound that suppresses monosodium urate crystal-induced inflammation in rats, an experimental model for acute gouty arthritis.
P2860
Q26774863-BDB84A97-8C2C-40E6-B382-FA1ED9BC93D5Q28265676-02A3E9CA-EA9D-4C3C-8E76-3F0AC483C9F5Q28543261-5297CF31-EA08-4C7C-ACB9-5CE2A4F7FBF8Q34303993-754354B0-C4F6-474E-BFDB-3B98B3893272Q34636225-8ACEADEC-D17A-46E3-9AD0-4CB383CA93A9Q34799654-D671E884-B4A0-435F-96F1-6FC67B535DABQ35186720-4927DDDB-0BED-478D-8F13-C8DCBF99ECECQ35643985-0CD2885C-FCE8-4895-9434-6B16A8183518Q35875538-A41B76DC-EABA-404A-84D1-C21EDF35634BQ35946872-F8AB997D-E0B6-4001-8E92-514A5CC472DFQ35999175-A4BCFC60-C2BA-4364-AA3A-C19ABDAE79BAQ36158922-FD6DC097-179B-48BE-933D-0B03D2F1D208Q36390177-715D76BE-14C6-4E36-923C-9D94FCECB9E7Q36515484-F1E40BDE-AF3B-44EB-8880-A1FBC6CFE261Q36713991-6E803E61-000B-4157-A407-ACA59D3A49B8Q36829387-E3BD1286-F2C7-466A-B0A1-2946A8146D41Q36903272-82DB16BF-06FF-4C8A-BA99-066DD34EB1CCQ37190929-ACB52FA5-4DC8-4FF5-B814-64F7DBAB9A41Q37559660-9FD3D03E-5212-4AA9-8C1E-3A613B9AE65EQ37590124-A3922DC6-E891-4EAF-9EB7-CFF3F3A977BFQ37737949-0AD77F6B-8277-4F4F-86BD-33A4EE7F3027Q37829674-897ED83F-9714-458E-B944-6F1B4746BD5EQ37957867-52468AC3-3153-4EA1-B8C6-16B56978754AQ37971360-F042F31D-A6D1-426E-8078-F6549E7F3F51Q38076334-98CFDA8E-A717-4456-BC79-7285441FE979Q38172880-B494A542-C374-4777-8215-387C6A2223CBQ38303334-97900002-3420-4C0D-9E85-569DACEE98AAQ38993319-9449207F-0E54-4A58-92EA-68452D08B1E9Q39036848-36C83274-67F3-4290-B55B-57D737F1BCBAQ39299592-77E6A3BD-5352-42EB-B786-D86CFC3E626EQ39740368-306CCC68-00A4-4EB5-920D-7BA090974224Q39889813-40FD4A0F-4A96-40E5-8440-F9F03381D492Q40093877-12DE5219-2416-47BE-B948-2B3958D20CC7Q40108109-3DFAEF52-8988-46F1-A867-6AA11B58BA4BQ40448592-E75965D0-C3C2-4C41-A2FB-5B810F43ADEFQ41475808-B5A8B9AF-F12F-41DD-8D89-259E8C5138E9Q42370099-7C89C6EC-5317-4648-BC5B-BB2B3CCF58EBQ42743044-AC078D13-F57A-4911-BF0F-0FCAE37BC359Q42869354-70F7756A-CE51-450C-ADC1-695E6432A07AQ43414960-E027EB7B-FFEE-46CF-8861-35B4D9F71C70
P2860
Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Hyperalgesia, synovitis and mu ...... imal model of gouty arthritis.
@en
Hyperalgesia, synovitis and mu ...... imal model of gouty arthritis.
@nl
type
label
Hyperalgesia, synovitis and mu ...... imal model of gouty arthritis.
@en
Hyperalgesia, synovitis and mu ...... imal model of gouty arthritis.
@nl
prefLabel
Hyperalgesia, synovitis and mu ...... imal model of gouty arthritis.
@en
Hyperalgesia, synovitis and mu ...... imal model of gouty arthritis.
@nl
P2093
P921
P356
P1476
Hyperalgesia, synovitis and mu ...... nimal model of gouty arthritis
@en
P2093
D M Hylton
G D Yancopoulos
J Reinhardt
L Macdonald
R A Terkeltaub
R Liu-Bryan
P304
P356
10.1136/ARD.2009.109355
P407
P577
2009-06-14T00:00:00Z